Generic Name and Formulations:
Unoprostone isopropyl 0.15%; oph soln; contains benzalkonium chloride.
Company:
Sucampo Pharma, LLC
Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.
1 drop twice daily.
Not established.
Prostanoid (docosanoid).
Active intraocular inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Contact lenses (remove; may reinsert lenses 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers.
Allow at least 5 minutes between application of other topical ophthalmic agents.
Burning/stinging, dry eyes, itching, increased length of eyelashes, increased ocular pigmentation (iris, periorbital tissues, eyelashes), abnormal vision, eyelid disorder, foreign body sensation, lacrimation disorder.
Renal.
NO
Soln—5mL